Determinants of hepatitis B virus surface antigen positivity in adults attending sexually transmitted disease clinics in Italy Chronic carriers of hepatitis B virus (HBV) infection (HBsAg positive subjects) represent the main source of infection in a community and are a population at highly increased risk of developing chronic liver diseases and primary hepatocellular carcinoma. A clear definition of their characterstics may offer the opportunity to focus more specific preventive campaigns. With this perspective we have analysed data from a cross-sectional epidemiological survey of patients attending sexually transmitted diseases (STD) clinics.'
Included in this study were subjects who referred themselves for the first time for suspected STD or STD treatment between March 1989 and December 1990 to two STD clinics in Bergamo and Brescia, Lombardy, Northern Italy. At the time of clinical registration, patients were asked to complete a standard questionnaire on their general characteristics and habits. Further, a blood sample was taken to establish the HBsAg status, HIV status, and to perform VDRL and TPHA tests according to standard methods. No subject had clinical or laboratory evidence of acute HBV infection. A total of 588 patients (457 men, 131 women; median age 30 years, range 17-65) agreed to participate. Less than 3% of eligible subjects refused to enter the study. The association between the variables considered and HBsAg serological status was estimated with multivariate odds ratios (OR) and their 95% confidence intervals (CI). Included in the regression equations were terms for age, sex, marital status, number of sexual partners, homosexuality in men, intravenous drug use and, in turn, various indicators of STD history or current infection.
HBsAg positivity was found in 42 subjects (7.1%, 95% CI from 5.2 to 9.9) out of the 588 screened. The prevalence of HBsAg positivity increased with age, from 4.9% in subjects aged 24 years or less to 8.6% in those aged 35 years or more. Compared with subjects aged 24 years or less, the estimated OR was 1.3 for those aged 25-34 and 1.9 for those 2 35; the trend in risk was however not statistically significant (table) . Women tended to have a lower prevalence of infection than men (5.3% vs 7.7%), the corresponding OR being 0.4 (95% CI 0-2-0.8). Intravenous drug use was strongly related with the risk of HBsAg positivity: compared with never users, ever users had an estimated OR of positive HBsAg of 4.3 (95% CI 1.9-9.8). The risk of HBsAg positivity increased with the number of reported Accepted for publication 1 January 1992.
Emerging incidence of vulval intraepithelial neoplasia in young women with genital warts
Historically, vulval intra-epithelial neoplasia (VIN) has been considered to be an uncommon disease, seen usually in the post-menopausal woman. In a study at The Middlesex Hospital in London, the mean age for females withVIN was 63 years' although recent reports from Campion et al2 suggest a modal age of 30 years and that the incidence in the young female is increasing. In our clinic, in the short space of 11 months, we have diagnosed nine cases ofVIN and we feel its incidence is probably even commoner in young females than it is generally believed to be, especially amongst those attending genitourinary clinics.
All new patients with genital warts were questioned to assess the presence or absence of pruritus, burning, dyspareunia or discolouration of skin. These are the commonest symptoms ofVIN. All patients denied past histories of sexually transmitted diseases (STDs), including HSV. All suspicious lesions were biopsied. Of 1 1 cases biopsied, nine showed VIN on histology ( 
